{"id":157076,"date":"2021-10-20T17:09:26","date_gmt":"2021-10-20T21:09:26","guid":{"rendered":"https:\/\/www.one.org\/us\/?post_type=one_press&amp;p=157076"},"modified":"2021-10-20T17:09:26","modified_gmt":"2021-10-20T21:09:26","slug":"one-statement-on-fda-approval-of-boosters","status":"publish","type":"one_press","link":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/","title":{"rendered":"ONE statement on FDA approval of boosters"},"content":{"rendered":"<p><span style=\"font-weight: 400\">WASHINGTON \u2014 The ONE Campaign issued the below statement today after the Food and Drug Administration authorized the expansion of booster shots for Moderna and Johnson &amp; Johnson recipients. This comes amidst an ongoing vaccine access crisis in low-income countries, where some immunocompromised individuals and first responders have yet to receive a single COVID-19 dose.\u00a0<\/span><\/p>\n<p><b>Tom Hart, Acting CEO at ONE:<\/b><\/p>\n<p><span style=\"font-weight: 400\">\u201cThe reality is, the more wealthy countries use booster shots, the further we will be from ending the pandemic. While some argue that we can both administer boosters and vaccinate the world, the simple fact is that boosters divert supply from an urgent area of need \u2014\u00a0 administering first shots around the world. Wealthy countries are already woefully off track in delivering the vaccines they have promised to share to date, and it will take significant ambition, funding, and speed to reach the goal of vaccinating 70 percent of the world by September 2022.\u201d<\/span><\/p>\n<p><span style=\"font-weight: 400\">\u201cAs we have seen with the delta variant, the longer we wait to vaccinate the world, the higher the threat for us at home. This isn\u2019t just a global health issue, it\u2019s a national security and economic crisis.\u201d<\/span><\/p>\n<p><b>Background<\/b><span style=\"font-weight: 400\">:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">Nearly 74% of vaccines<\/span><a href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fact.one.org%2Fgo%2F110646%3Ft%3D28%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3Dcovid19%26akid%3D130122.10100081.8I47H5&amp;data=04%7C01%7Csarah.swinehart%40one.org%7Cebe2bdd5718d46ea057208d98fcaf8be%7Cc85ffd8d5f42467aaa6978509c882c4e%7C0%7C0%7C637698924198433970%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=ADhLzTNfOI1kgx%2FWXLq%2FtWuWCgbgWv%2FIh83bh7AViF0%3D&amp;reserved=0\"> <span style=\"font-weight: 400\">administered globally<\/span><\/a><span style=\"font-weight: 400\"> have been in high- and upper-middle income countries, compared to just 0.4% in low-income countries.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400\"><span style=\"font-weight: 400\">84% of the COVID-19 vaccine doses that G7 countries have committed to lower and lower-middle income countries <\/span><a href=\"https:\/\/nam11.safelinks.protection.outlook.com\/?url=https%3A%2F%2Fact.one.org%2Fgo%2F139060%3Ft%3D60%26utm_source%3Demail%26utm_medium%3Demail%26utm_campaign%3Dcovid19%26akid%3D130122.10100081.8I47H5&amp;data=04%7C01%7Csarah.swinehart%40one.org%7Cebe2bdd5718d46ea057208d98fcaf8be%7Cc85ffd8d5f42467aaa6978509c882c4e%7C0%7C0%7C637698924198633858%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&amp;sdata=kXHf%2B1RYjrUj7isTL6X7lXmz%2BPbm%2BjCSMs1t1P%2Ft1XI%3D&amp;reserved=0\"><span style=\"font-weight: 400\">have yet to be delivered<\/span><\/a><span style=\"font-weight: 400\"> (as of October 18, 2021).<\/span><\/li>\n<\/ul>\n<div class=\"buffer\"><\/div>","protected":false},"excerpt":{"rendered":"<p>WASHINGTON \u2014 The ONE Campaign issued the below statement today after the Food and Drug Administration authorized the expansion of booster shots for Moderna and Johnson &amp; Johnson recipients. This comes amidst an ongoing vaccine access crisis in low-income countries, where some immunocompromised individuals and first responders have yet to receive a single COVID-19 dose.\u00a0 [&hellip;]<\/p>\n","protected":false},"author":17,"featured_media":0,"template":"","meta":{"_acf_changed":false,"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","footnotes":""},"contributor":[],"class_list":["post-157076","one_press","type-one_press","status-publish","hentry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.1 (Yoast SEO v27.1.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ONE statement on FDA approval of boosters - ONE.org US<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ONE statement on FDA approval of boosters\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON \u2014 The ONE Campaign issued the below statement today after the Food and Drug Administration authorized the expansion of booster shots for Moderna and Johnson &amp; Johnson recipients. This comes amidst an ongoing vaccine access crisis in low-income countries, where some immunocompromised individuals and first responders have yet to receive a single COVID-19 dose.\u00a0 [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\" \/>\n<meta property=\"og:site_name\" content=\"ONE.org US\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ONE\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.one.org\/us\/wp-content\/uploads\/sites\/2\/2023\/09\/GA_share_1200x628-768x402-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"768\" \/>\n\t<meta property=\"og:image:height\" content=\"402\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@ONEinAmerica\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"NewsArticle\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"ONE statement on FDA approval of boosters\",\"datePublished\":\"2021-10-20T21:09:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\"},\"wordCount\":242,\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\",\"url\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\",\"name\":\"ONE statement on FDA approval of boosters - ONE.org US\",\"isPartOf\":{\"@id\":\"https:\/\/www.one.org\/us\/#website\"},\"datePublished\":\"2021-10-20T21:09:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.one.org\/us\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ONE statement on FDA approval of boosters\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.one.org\/us\/#website\",\"url\":\"https:\/\/www.one.org\/us\/\",\"name\":\"ONE.org\",\"description\":\"Driving economic opportunities and healthy lives in Africa\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.one.org\/us\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"\",\"url\":\"https:\/\/www.one.org\/us\/stories\/author\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ONE statement on FDA approval of boosters - ONE.org US","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/","og_locale":"en_US","og_type":"article","og_title":"ONE statement on FDA approval of boosters","og_description":"WASHINGTON \u2014 The ONE Campaign issued the below statement today after the Food and Drug Administration authorized the expansion of booster shots for Moderna and Johnson &amp; Johnson recipients. This comes amidst an ongoing vaccine access crisis in low-income countries, where some immunocompromised individuals and first responders have yet to receive a single COVID-19 dose.\u00a0 [&hellip;]","og_url":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/","og_site_name":"ONE.org US","article_publisher":"https:\/\/www.facebook.com\/ONE","og_image":[{"width":768,"height":402,"url":"https:\/\/www.one.org\/us\/wp-content\/uploads\/sites\/2\/2023\/09\/GA_share_1200x628-768x402-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_site":"@ONEinAmerica","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"NewsArticle","@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#article","isPartOf":{"@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/"},"author":{"name":"","@id":""},"headline":"ONE statement on FDA approval of boosters","datePublished":"2021-10-20T21:09:26+00:00","mainEntityOfPage":{"@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/"},"wordCount":242,"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/","url":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/","name":"ONE statement on FDA approval of boosters - ONE.org US","isPartOf":{"@id":"https:\/\/www.one.org\/us\/#website"},"datePublished":"2021-10-20T21:09:26+00:00","breadcrumb":{"@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.one.org\/us\/press\/one-statement-on-fda-approval-of-boosters\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.one.org\/us\/"},{"@type":"ListItem","position":2,"name":"ONE statement on FDA approval of boosters"}]},{"@type":"WebSite","@id":"https:\/\/www.one.org\/us\/#website","url":"https:\/\/www.one.org\/us\/","name":"ONE.org","description":"Driving economic opportunities and healthy lives in Africa","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.one.org\/us\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"","url":"https:\/\/www.one.org\/us\/stories\/author\/"}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"ONE.org US","distributor_original_site_url":"https:\/\/www.one.org\/us","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press\/157076","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press"}],"about":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/types\/one_press"}],"author":[{"embeddable":true,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/users\/17"}],"version-history":[{"count":0,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/one_press\/157076\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/media?parent=157076"}],"wp:term":[{"taxonomy":"contributor","embeddable":true,"href":"https:\/\/www.one.org\/us\/wp-json\/wp\/v2\/contributor?post=157076"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}